REGENERON PHARMACEUTICALS INC (REGN)
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Sector: Health Care
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
Director information for REGN
| Ticker | Position | Age | Qualifications and Experience | Committee Memberships | Filing Year |
|---|---|---|---|---|---|
| REGN | Director | 85 | ["Regental Professor of Molecular Genetics and Internal Medicine","Chair of the Department of Molecular Genetics at The University of Texas Southwestern Medical Center","Member of the boards of trustees of The Rockefeller University and the Howard Hughes Medical Institute","Nobel Prize for Physiology or Medicine in 1985","U.S. National Medal of Science in 1988","Member of The National Academy of Sciences","Member of The National Academy of Medicine","Member of The Royal Society of London"] | ["Corporate Governance and Compliance Committee","Technology Committee"] | 2026 |
Biography sourced from the proxy statement filing.
Age: 85 Director since: 1991 Board and Committee Membership 2025 Attendance Board of Directors: 14/15 Corporate Governance and Compliance Committee: 5/5 Technology Committee: 2/2 Career Highlights Regental Professor of Molecular Genetics and Internal Medicine and Chair of the Department of Molecular Genetics at The University of Texas Southwestern Medical Center at Dallas since 1977 Member of the boards of trustees of The Rockefeller University and the Howard Hughes Medical Institute Nobel Prize for Physiology or Medicine in 1985 (jointly with Dr. Brown) U.S. National Medal of Science in 1988 (jointly with Dr. Brown) Experience and Expertise Industry Experience Executive/Leadership Experience Science/Biotech Background Research/Academic Experience Scientific Society Memberships The National Academy of Sciences The National Academy of Medicine The Royal Society of London Reason for Nomination Dr. Goldstein s extensive research experience, his distinguished scientific and academic credentials, including his receipt of the Nobel Prize for Physiology or Medicine in 1985, and his substantial understanding of the Company gained through his service as a director, led to the board s decision to nominate Dr. Goldstein for reelection to the board.